Cardinal Health (NYSE:CAH) Given New $142.00 Price Target at JPMorgan Chase & Co.

Cardinal Health (NYSE:CAH) had its price objective raised by equities research analysts at JPMorgan Chase & Co. from $132.00 to $142.00 in a research report issued on Friday,Benzinga reports. The firm presently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price objective would suggest a potential upside of 9.96% from the company’s previous close.

A number of other equities analysts have also weighed in on CAH. Evercore ISI upgraded Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective for the company in a research note on Tuesday, January 7th. StockNews.com cut shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd. Morgan Stanley lifted their price target on Cardinal Health from $127.00 to $136.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 17th. Citigroup increased their target price on shares of Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research report on Friday, January 10th. Finally, Mizuho began coverage on Cardinal Health in a report on Wednesday, December 4th. They issued an “outperform” rating and a $139.00 price target for the company. Four investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and a consensus price target of $134.64.

Cardinal Health Price Performance

Shares of CAH stock traded down $0.17 during mid-day trading on Friday, hitting $129.13. 328,427 shares of the stock traded hands, compared to its average volume of 1,895,174. Cardinal Health has a 52-week low of $93.17 and a 52-week high of $129.68. The stock has a market cap of $31.25 billion, a P/E ratio of 25.12, a P/E/G ratio of 1.57 and a beta of 0.63. The stock’s fifty day moving average is $121.15 and its two-hundred day moving average is $112.70.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Friday, November 1st. The company reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.62 by $0.26. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The company had revenue of $52.28 billion during the quarter, compared to analysts’ expectations of $50.90 billion. During the same period last year, the business posted $1.73 earnings per share. The firm’s revenue was down 4.3% compared to the same quarter last year. As a group, equities analysts forecast that Cardinal Health will post 7.82 EPS for the current fiscal year.

Institutional Trading of Cardinal Health

Large investors have recently bought and sold shares of the company. Eastern Bank purchased a new stake in shares of Cardinal Health in the 3rd quarter worth about $25,000. Frazier Financial Advisors LLC grew its position in shares of Cardinal Health by 69.8% in the third quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock valued at $28,000 after purchasing an additional 104 shares during the last quarter. Hara Capital LLC purchased a new position in shares of Cardinal Health during the 3rd quarter worth approximately $31,000. AM Squared Ltd acquired a new position in shares of Cardinal Health during the 3rd quarter worth approximately $33,000. Finally, Carolina Wealth Advisors LLC purchased a new stake in Cardinal Health in the 3rd quarter valued at approximately $47,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.